Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

被引：2
|
作者：
Levy, Benjamin Philip
Paz-Ares, Luis G.
Bennouna, Jaafar
Felip, Enriqueta
Abreu, Delvys Rodriguez
Isla, Dolores
Barlesi, Fabrice
Molinier, Olivier
Madelaine, Jeannick
Audigier-Valette, Clarisse
Kim, Sang-We
Ozguroglu, Mustafa
Erman, Mustafa
Badin, Firas Benyamine
Mekhail, Tarek
Scheff, Ronald J.
Riess, Jonathan W.
机构：
[1] Johns Hopkins Univ, Sch Med, Sibley Mem Hosp, Sidney Kimmel Comprehens Canc Ctr, Washington, DC USA
[2] Hosp Univ 12 Octubre, Madrid, Spain
[3] CNIO, Madrid, Spain
[4] Hop G & L Laennec, Nantes, France
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[7] Hosp Clin Lozano Blesa, Zaragoza, Spain
[8] Hosp Nord Serv Oncol, Marseille, France
[9] Ctr Hosp Le Mans, Le Mans, France
[10] Hopital Cote Nacre, Caen, France
[11] Hop St Musse, Toulon, France
[12] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[13] Istanbul Univ, Istanbul, Turkey
[14] Hacettepe Univ, Inst Canc, Ankara, Turkey
[15] Baptist Hlth Lexington Canc Ctr, Lexington, KY USA
[16] Florida Hosp Canc Inst, Orlando, FL USA
[17] Weill Cornell Med Coll, New York, NY USA
[18] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.TPS9117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9117
引用
收藏
页数：1
相关论文
共 50 条
  • [31] BRACHYTHERAPY FOR STAGE IIIB SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX: SURVIVAL AND TOXICITY
    Zuliani, Antonio Carlos
    Cunha, Maercio de Oliveira
    Esteves, Sergio C. B.
    Teixeira, Julio Cesar
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2010, 56 (01): : 37 - 40
  • [32] The multimodality therapy for patients with advanced non-small cell lung cancer (stage IIIB and IV).
    Guo, H
    Li, Z
    Cheng, H
    Sun, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 707S - 707S
  • [33] PLUX-Lung 8 phase III trial: Analysis of long-term response to second-line afatinib in patients with advanced squamous cell carcinoma (SCC) of the lung
    Yang, J. C-H.
    Goss, G.
    Felip, E.
    Lu, S.
    Ardizzoni, A.
    Gadgeel, S. M.
    Georgoulias, V.
    Dupuis, N.
    Ehrnrooth, E.
    Soria, J-C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Efficacy and safety of pegvorhyaluronidase alfa (PEGPH20; PVHA) and pembrolizumab (pembro) combination therapy in patients (Pts) with stage III/IV non-small cell lung cancer (NSCLC)
    Ward, J. P.
    Shum, M.
    Bertino, E.
    Lin, V.
    Kuruvadi, V.
    Heineman, T.
    ANNALS OF ONCOLOGY, 2019, 30
  • [35] Efficacy and outcome analysis: Combination of Endostar and chemotherapy as a neoadjuvant treatment of stage IIIA/IIIB squamous cell lung cancer
    Cao, Feiyi
    Ding, Sijie
    Gu, Cuiping
    Zhou, Yao
    Hong, Wei
    Jin, Ying
    ONCOLOGY LETTERS, 2024, 27 (01)
  • [36] Efficacy of Icotinib treatment in patients with stage IIIb/IV non-small cell lung cancer
    Qin, Na
    Yang, Xinjie
    Zhang, Quan
    Li, Xi
    Zhang, Hui
    Lv, Jialin
    Wu, Yuhua
    Wang, Jinghui
    Zhang, Shucai
    THORACIC CANCER, 2014, 5 (03) : 243 - 249
  • [37] Chemotherapy of stage IIIB and IV non-small-cell lung cancer
    Cojean, I
    LeChevalier, T
    ANNALS OF ONCOLOGY, 1995, 6 : 41 - 44
  • [38] A PHASE II STUDY OF FIRST-LINE BORTEZOMIB (B) IN PATIENTS (PTS) WITH STAGE IIIB/IV NON-SMALL-CELL LUNG CANCER (NSCLC)
    Planchard, D.
    Besse, B.
    Meric, J. B.
    Veillard, A. S.
    Pignon, J. P.
    Chan, K.
    Mathiot, C.
    Lumbroso, J.
    Lafontaine, C.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 96 - 96
  • [39] Axitinib in combination with pembrolizumab in patients (pts) with advanced renal cell carcinoma (aRCC): Preliminary safety and efficacy results
    Atkins, M. B.
    Plimack, E. R.
    Puzanov, I.
    Fishman, M. N.
    McDermott, D.
    Cho, D. C.
    Vaishampayan, U.
    George, S.
    Olencki, T.
    Tarazi, J.
    Rosbrook, B.
    Fernandez, K.
    Keefe, S.
    Choueiri, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [40] Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
    Lim, Sun M.
    Kang, Seong-san
    Kim, Dong K.
    Lee, Soo-Hwan
    Synn, Chun-Bong
    Baek, Sujeong
    Yang, Seung M.
    Han, Yu J.
    Kim, Mi H.
    Han, Heekyung
    Na, Kwangmin
    Kim, Young T.
    Yun, Mi R.
    Kim, Jae H.
    Byeon, Youngseon
    Kim, Young S.
    Lee, Jii B.
    Hong, Min H.
    Curtin, Joshua C.
    Patel, Bharvin
    Bergiers, Isabelle
    Pyo, Kyoung-Ho
    Cho, Byoung C.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (07): : 1748 - 1764
12345